Diagnosis and Treatment of Post-Streptococcal Complications

Indications for Anti-Streptolysin O (ASO) Testing

• The American Heart Association recommends ASO testing to confirm previous streptococcal infection in patients with suspected post-streptococcal complications such as acute rheumatic fever or acute glomerulonephritis, but not for diagnosing acute pharyngitis 1, 2
• ASO testing is indicated in patients with symptoms suggestive of acute rheumatic fever, such as migratory arthritis, carditis, chorea, erythema marginatum, and subcutaneous nodules, to confirm previous streptococcal infection 1, 2
• ASO testing is also indicated in patients with suspected post-streptococcal glomerulonephritis, characterized by hematuria, proteinuria, edema, and hypertension 1, 2

Interpretation of ASO Test Results

• The ASO test begins to rise approximately 1 week after infection and peaks between 3-6 weeks, with a sensitivity of 80-90% 1
• The anti-DNase B test begins to rise 1-2 weeks after infection and peaks between 6-8 weeks, with a sensitivity of 90-95% 1, 2
• Both ASO and anti-DNase B tests can remain elevated for several months after uncomplicated infections, making it essential to consider the clinical context and other laboratory findings 1

Treatment of Post-Streptococcal Complications

• The primary treatment for patients with positive ASO and suspected acute rheumatic fever is to eradicate the streptococcal infection with antibiotics to prevent permanent cardiac valve damage and mortality 3
• The American Heart Association recommends penicillin V oral (500 mg twice or three times a day for 10 days) or amoxicillin oral (50 mg/kg once a day for 10 days) as first-line treatment for acute rheumatic fever 1, 3
• Alternative treatments for patients allergic to penicillin include cefalosporins, clindamycin, and azithromycin, although resistance patterns should be considered 1, 3

Duration of Treatment

• The treatment duration for post-streptococcal complications is always 10 days with oral antibiotics, as shorter courses increase the risk of acute rheumatic fever 3
• The primary objective of treatment is to prevent acute rheumatic fever, which is critical for reducing mortality and morbidity 3
• The secondary objective is to prevent suppurative complications such as peritonsillar abscess, cervical lymphadenitis, and mastoiditis 3

Management of Significantly Elevated ASO Titer

Initial Clinical Assessment and Diagnostic Approach

• The American Academy of Pediatrics recommends repeat clinical assessment at 3-5 days after initiating therapy, then weekly until asymptomatic, and to observe post-therapy for sufficient time to detect relapse or development of post-streptococcal nephritis or carditis 4

Treatment Protocol and Prophylaxis

• The Infectious Diseases Society of America suggests that antibiotic therapy is mandatory to eradicate streptococcal infection and prevent permanent cardiac valve damage, with penicillin V 500 mg PO twice or three times daily for 10 days, or amoxicillin 50 mg/kg PO once daily for 10 days 4
• The American Heart Association recommends continuous oral penicillin prophylaxis for 5 years or until age 21 (whichever is longer) without carditis, or 10 years/until age 21 with carditis without residual valve disease, to prevent recurrence of acute rheumatic fever 4

Acute Rheumatic Fever and Post-Streptococcal Reactive Arthritis Diagnosis and Management

Diagnostic Approach

• Inflammatory markers, such as ESR and CRP, should be elevated in patients with acute rheumatic fever or post-streptococcal reactive arthritis 5

Differential Diagnosis

• Adult-onset Still's disease presents with quotidian fever >39°C, salmon-pink rash, and extremely elevated ferritin, and should be considered in the differential diagnosis of migratory arthritis 6, 7

Treatment Protocol

• The American Heart Association recommends monitoring for cardiac involvement in all post-streptococcal cases, although this specific recommendation is not found in the provided text, the general principle of monitoring is supported by various guidelines, including those from the American College of Cardiology, which emphasizes the importance of cardiac evaluation in patients with a history of rheumatic fever 5, 7

Diagnostic and Management Strategies for High ASO Titre with Positive Rheumatoid Factor

1. Confirm Presence of True Inflammatory Activity

• Before escalating any immunosuppressive therapy, verify that the patient has objective evidence of inflammatory disease activity (e.g., clinical synovitis, markedly elevated ESR/CRP). 8

2. Apply Jones Criteria for Acute Rheumatic Fever (ARF)

• Diagnosis of ARF requires ≥ 2 major criteria or 1 major + ≥ 2 minor criteria together with laboratory evidence of a preceding streptococcal infection. 9
• Major criteria include:
  
  • Carditis (clinical or subclinical). 9
  • Migratory polyarthritis. [9][10]
• Minor criteria include:
  
  • Arthralgia (when arthritis is not counted as a major criterion). 9
  • Prolonged PR interval on ECG. 9
  • Elevated inflammatory markers (ESR or CRP). 9

3. Cardiac Evaluation in Suspected Post‑Streptococcal Disease

• All patients with possible ARF should receive an ECG to assess PR interval and an echocardiogram to detect valve lesions, pericardial effusion, or ventricular dysfunction, as cardiac involvement dictates prognosis and prophylaxis duration. 9

4. Interpretation of Rheumatoid Factor (RF)

• In checkpoint‑inhibitor‑associated arthritis, RF is positive in only a minority of cases (≈ 18–246 IU/mL) and often occurs without anti‑CCP antibodies. [11][12]
• RF positivity alone does not confirm rheumatoid arthritis; clinical synovitis and preferably anti‑CCP positivity are required for a definitive RA diagnosis. [8][10]

5. Laboratory and Imaging Work‑up for Inflammatory Arthritis

• Anti‑CCP antibody testing should be performed when RA is suspected because it offers greater specificity than RF. 10
• Musculoskeletal ultrasound or MRI are recommended when the clinical exam is equivocal, as imaging detects synovitis 2.18‑fold more frequently than examination alone. 13
• Plain radiographs of the hands and feet are advised to evaluate for erosive changes that support an inflammatory arthropathy. 13

6. Referral and Therapeutic Decision‑Making

• Rheumatology referral is indicated for patients with persistent inflammatory arthritis who may require disease‑modifying antirheumatic drugs (DMARDs). [11][12]
• If ARF is excluded but true synovitis is present with a positive RF, consider rheumatoid arthritis or other inflammatory arthropathies as the underlying diagnosis. 8

7. Key Pitfalls to Avoid

• Do not prescribe antibiotics solely for an elevated ASO titre; treatment is warranted only when ARF or post‑streptococcal glomerulonephritis is confirmed. 8
• Do not diagnose rheumatoid arthritis based on RF alone; require clinical synovitis and, when possible, anti‑CCP confirmation. [8][10]
• Do not intensify immunosuppression in the absence of confirmed inflammatory disease activity; laboratory abnormalities without clinical inflammation should not trigger therapy escalation. 8